Literature DB >> 6585217

Childhood cancer survival trends in Queensland 1956-80.

W R McWhirter, V Siskind.   

Abstract

The true survival rates for the various forms of childhood cancer are best determined from a population-based study rather than from the results of clinical trials. Population-based survival rates have been calculated for four periods between 1956 and 1980 in Queensland. There was a significant improvement in survival for children who developed cancer after 1973 compared with those diagnosed before this date. There has however been no significant improvement in the survival rate for childhood cancer overall, or for acute lymphoblastic leukaemia since 1973. Over the 25 year period significant trends in survival rates were seen in acute lymphoblastic leukaemia, non-Hodgkin's lymphoma, Hodgkin's disease, Wilms' tumour, medulloblastoma, and retinoblastoma. No such trend was seen for acute non-lymphoblastic leukaemia, neuroblastoma, rhabdomyosarcoma, juvenile or anaplastic astrocytoma, brain stem glioma, histiocytosis X, or bone tumours. There is a need for continuing research into better methods of treatment of childhood cancer.

Entities:  

Mesh:

Year:  1984        PMID: 6585217      PMCID: PMC1976774          DOI: 10.1038/bjc.1984.79

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  10 in total

1.  Trends in cancer survival among U.S. white children, 1955-1971.

Authors:  M H Myers; H W Heise; F P Li; R W Miller
Journal:  J Pediatr       Date:  1975-11       Impact factor: 4.406

2.  The treatment of Wilms' tumor: results of the Second National Wilms' Tumor Study.

Authors:  G J D'Angio; A Evans; N Breslow; B Beckwith; H Bishop; V Farewell; W Goodwin; L Leape; N Palmer; L Sinks; W Sutow; M Tefft; J Wolff
Journal:  Cancer       Date:  1981-05-01       Impact factor: 6.860

3.  Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2).

Authors:  J R Anderson; J F Wilson; D T Jenkin; A T Meadows; J Kersey; R R Chilcote; P Coccia; P Exelby; J Kushner; S Siegel; D Hammond
Journal:  N Engl J Med       Date:  1983-03-10       Impact factor: 91.245

Review 4.  Intracranial tumors: response and resistance to therapeutic endeavors, 1970-1980.

Authors:  H J Bloom
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982-07       Impact factor: 7.038

Review 5.  Medulloblastoma in children: increasing survival rates and further prospects.

Authors:  H J Bloom
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982-11       Impact factor: 7.038

Review 6.  Hodgkin's disease in children.

Authors:  R Derek; T Jenkin; M P Berry
Journal:  Semin Oncol       Date:  1980-06       Impact factor: 4.929

7.  Radiation treatment for medulloblastoma. A 21-year review.

Authors:  M P Berry; R D Jenkin; C W Keen; B D Nair; W J Simpson
Journal:  J Neurosurg       Date:  1981-07       Impact factor: 5.115

8.  Non-Hodgkin's lymphoma in children. A comparative study of two modalities of therapy.

Authors:  N Wollner; J H Burchenal; P H Lieberman; P Exelby; G D'Angio; M L Murphy
Journal:  Cancer       Date:  1976-01       Impact factor: 6.860

Review 9.  Rhabdomyosarcoma.

Authors:  L S Bizer
Journal:  Am J Surg       Date:  1980-11       Impact factor: 2.565

10.  Incidence of childhood tumours in Queensland.

Authors:  W R McWhirter; J E Bacon
Journal:  Br J Cancer       Date:  1981-11       Impact factor: 7.640

  10 in total
  3 in total

1.  Improvements in survival from childhood cancer: results of a population based survey over 30 years.

Authors:  J M Birch; H B Marsden; P H Jones; D Pearson; V Blair
Journal:  Br Med J (Clin Res Ed)       Date:  1988-05-14

2.  Survival rates of childhood cancer patients in Osaka, Japan, 1975-1984.

Authors:  W Ajiki; A Hanai; H Tsukuma; T Hiyama; I Fujimoto
Journal:  Jpn J Cancer Res       Date:  1995-01

3.  Incidence of childhood cancer in Osaka, Japan, 1971-1988: reclassification of registered cases by Birch's scheme using information on clinical diagnosis, histology and primary site.

Authors:  W Ajiki; A Hanai; H Tsukuma; T Hiyama; I Fujimoto
Journal:  Jpn J Cancer Res       Date:  1994-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.